Goldman Sachs initiated coverage on Cue Health with a new price target
$HLTH
Biotechnology: Laboratory Analytical Instruments
Industrials
Goldman Sachs initiated coverage of Cue Health with a rating of Buy and set a new price target of $19.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/14/2024 | Buy → Neutral | BTIG Research | |
| 10/19/2021 | $18.00 | Buy | BTIG Research |
| 10/19/2021 | $12.00 | Equal-Weight | Morgan Stanley |
| 10/19/2021 | $19.00 | Buy | Goldman Sachs |
| 10/19/2021 | $14.00 | Outperform | Cowen & Co. |